TrialThe Journal of infection2024

Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes.

Gail Hayward et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.